Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
|Product:||Lipiodol Ultra Fluid|
|Active Ingredient:||Iodised oil 38%w/w|
|Dosage Form:||Solution for injection|
|New Zealand Sponsor:||Obex Medical Limited|
|Manufacturers:||Guerbet, Aulnay Sous Bois, France
Delpharm Tours, Chambray Les Tours, France
Dated this 23rd day of April 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).